Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder ...

The researchers captured eight unique structural models and 16 cryogenic electron microscopy maps of the receptor with both ...

Por JOE REEDYEl receptor abierto de los Bengals de Cincinnati, Ja’Marr Chase, fue suspendido sin sueldo por un juego el lunes ...

Jay Lalezari, CEO of CytoDyn, explains how the CCR5 receptor has emerged as a pivotal target in metastatic cancers due to its ...

A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

Often dismissed as a minor ailment, migraine is a debilitating neurological disease affecting hundreds of thousands of New ...

Retatrutide is a powerful experimental weight loss drug that currently lacks FDA approval. Learn how it works, plus the legal and safety risks of buying retatrutide online.

The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn ...

Until now, researchers assumed that schizophrenia, anxiety disorders or depression arise from an interplay of many different ...

A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) ...